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ABSTRACT Retrovirus budding is a key step in the virus replication cycle. Nonetheless, very little is known about the underlying
mechanism of budding, primarily due to technical limitations preventing visualization of bud formation in real time. Methods
capable of monitoring budding dynamics suffer from insufﬁcient resolution, whereas other methods, such as electron microscopy,
do not have the ability to operate under physiological conditions. Here we applied atomic force microscopy to real-time visual-
ization of individual Moloney murine leukemia virus budding events. By using a single-particle analysis approach, we were able to
observe distinct patterns in budding that otherwise remain transparent. We ﬁnd that bud formation follows at least two kinetically
distinct pathways. The majority of virions (74%) are produced in a slow process (.45 min), and the remaining particles (26%)
assemble via a fast process (,25min). Interestingly, repetitive budding from the same site was seen to occur in only two locations.
This ﬁnding challenges the hypothesis that viral budding occurs from distinct sites and suggests that budding is not restricted
laterally. In this study, we established a method to monitor the ﬁne dynamics of the virus budding process. Using this single-
particle analysis to study mutated viruses will enable us to gain additional insight into the mechanisms of viral budding.
INTRODUCTION
Assembly and budding of a new virus is a fundamental step
in retrovirus replication. In g-retroviruses, such as the human
immunodeﬁciency virus (HIV) and Moloney murine leuke-
mia virus (MLV), both of these processes occur at the plasma
membrane of the infected cell. Expression of a single viral
protein, termed Gag, is sufﬁcient to drive assembly and bud-
ding and results in the formation of virus-like particles (1,2).
Gag proteins are attracted to the plasma membrane by their
myristoyl group (3,4), where they associate with other Gag
proteins through speciﬁc domains (5,6). Mutations of these
domains were shown to signiﬁcantly reduce (5,7) or even
completely inhibit (8–10) virion production. Initially, self-
assembly of Gag is characterized by the formation of an
electron dense protein shell beneath the plasma membrane,
as observed by electron microscopy (EM) (11). As the as-
sembly process progresses, the Gag layer induces a protru-
sion in the plasma membrane which grows until a new virion
is tethered to the cell membrane by a stalk. Lastly, the na-
scent virus is released from the plasma membrane by mem-
brane ﬁssion (11). Efﬁcient ﬁssion, in the late stages of
retroviral budding, requires interactions with cellular ma-
chineries involved in the endosomal pathway (12–14).
Mutations which block these interactions, either in Gag
(10,15,16) or in the cellular machinery (13,17), lead to bud-
ding defects. These mutations, termed late-domain mutants,
result in either arrested virions incapable of undergoing
ﬁssion or the formation of multiple virus particles tethered to
each other (13,18).
Retroviral budding has been extensively studied using
various EM methods (19,20). Thin-section transmission EM
imaging of cells infected with either HIV (11) or MLV (21)
shows various stages in viral budding, starting from assem-
bly and ending with the release of a nascent virus. Although
these studies provide extensive characterization of the struc-
tural aspects of viral budding, they require sample ﬁxation
and thus lack the ability to ﬁll a signiﬁcant hole in our
knowledge by providing a dynamic description of viral bud-
ding. In contrast, by using biochemical methods such as
pulse chase labeling, the kinetics of viral production was
studied (22). These biochemical studies provided valuable
insights into the budding process, but they were limited by
their ability to offer only averaged kinetics information,
which made them unsuited for use in detecting the presence
or otherwise of kinetically distinct budding mechanisms.
Clearly, whether budding occurs through a single or multiple
pathways has important implications for our understanding
of its mechanism. More recently, retroviral budding from
live cells has been studied by combining correlated ﬂuores-
cent and scanning electron microscopy (SEM) (23). In that
study, the release of single particles was followed by
tracking ﬂuorescently labeled virions. However, due to the
limitations associated with optical microscopy, the formation
of new virus particles could not be determined.
Despite substantial progress in the characterization of
retroviral budding, the underlying physical mechanism
remains poorly understood. In this study, we analyze single
MLV budding events by imaging live cells with the atomic
force microscope (AFM). The AFM has a similar lateral
resolution to the EM, which is sufﬁcient to image a single
virus particle. Indeed, the AFM has been used to acquire
high-resolution images of chemically ﬁxed virus particles
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(24–29) and to image nontreated virus particles and even
measure their mechanical properties (30–34). In a proof of
concept study, Haberle et al. demonstrated that pox virus
budding can be visualized by AFM (35). We show that MLV
particles bud via at least two kinetically distinct pathways.
The majority of MLV particles (74%) enter an arrested state
before being released, leading to a slow kinetics (.45 min).
The remaining 26% bud in one continuous action and show
fast kinetics (,25 min). Very rarely (,3%) were repetitive
budding events observed from the same site. This observa-
tion poses a challenge to the hypothesis that viral budding
occurs from unique sites on the plasma membrane. Our
results are the ﬁrst detailed analysis of single retrovirus
budding, to our knowledge, and establish the groundwork for




Standard NIH/3T3 murine ﬁbroblasts and 3T3 cells stably infected with
wild-type MoMLV (CL-1, a generous gift from Prof. Cunningham) were
cultured as described in Fan and Paskind (36). For AFM imaging, cells were
plated in 35 mm cell culture dishes and grown to ;50% conﬂuence. Cells
were typically imaged 24–48 h after plating. To maintain a high density of
viral budding events, only cells which were cultured for less than 10 pas-
sages were used.
AFM imaging of live cells
AFM imaging was carried out using a Bioscope with a Nanoscope IV
controller (Veeco, Santa Barbara, CA) that is mounted on an inverted optical
microscope (Axiovert 200M, Carl Zeiss, Heidelberg, Germany). Images of
cells were acquired in AFM tapping mode in a ﬂuid environment. Pyramidal
silicon nitride triangular cantilevers (with a nominal stiffness of 0.2 N/m
(DNP)) were used. Cantilevers have a nominal tip radius of 20 nm. To
properly maintain the cells, a temperature of 37C and an atmosphere with
5% CO2 levels were maintained during the entire duration of the mea-
surements using a CO2 controller (Carl Zeiss) and a temperature controller
(Model 3040, Newport, Irvine, CA). This was achieved by a microincubator
perfusion chamber (Model PDMI-2; Harvard Apparatus, Holliston, MA),
which holds a 35 mm cell culture dish and is attached to the microscope
stage.
Image rendering and kinetics analysis
Images of cells were rendered using the WSxM software (Nanotec Elec-
tronica, http://www.nanotec.es/progcorn.htm) (37). Virus particles were ini-
tially detected in the amplitude image, since it typically has better contrast
than the corresponding topographic (height) image. Once virus particles were
identiﬁed, their heights were determined manually by cross sectional proﬁles
from the topographic images. In this method, single particles were tracked
frame by frame to extract their budding kinetics pattern.
Electron microscopy
Cells were cultured on a microscope cover glass and ﬁxed by incubation
with a solution of 2% glutaraldehyde (EM grade) in 0.1 M sodium
cacodylate, pH 7.3 for at least 50 min at room temperature. After ﬁxation,
samples were immersed in 0.1% tannic acid for 20 min and rinsed in distilled
water, followed by 20 min incubation in 0.1% uranyl acetate solution. After
rinsing, samples were dehydrated by a series of solutions having increasing
ethanol concentrations, followed by critical point drying with liquid CO2.
Samples were sputter coated with a layer of 10 nm chromium. Cells and
viruses were viewed and photographed using an environmental scanning
electron microscope (Phillips XL-30, FEI, Eindhoven, The Netherlands).
RESULTS
Imaging MLV budding from live cells
Budding of MLV particles was imaged with the AFM
operated in tapping mode to minimize possible damage to
cells by the AFM probe (Fig. 1, A and B). For this study, the
cell line used was CL-1, which originates from a standard
NIH/3T3 mouse ﬁbroblast cell line that is chronically
infected with MLV (36). To maintain the health of the cells
throughout the entire duration of the measurements, both the
temperature and CO2 levels were controlled. Viability of the
FIGURE 1 AFM and SEM images of uninfected and MLV infected cells.
(A) An AFM amplitude image, acquired in tapping mode, of an uninfected
NIH/3T3 live cell. The apparent ﬁbril structures underneath the cell mem-
brane are likely to be associated with the cytoskeleton. Scan area is 24 3
24mm, 4103 410 pixels. Scale bar is 5mm. (B) A tapping mode AFM image
of an MLV infected NIH/3T3 live cell (CL-1). Virus particles at different
stages of budding appear as protrusions of different heights on the cell
membrane. Due to convolution between the AFM tip and the virus, these
protrusions appear larger than their actual dimensions. Scan area is 15 3 15
mm, 5123 512 pixels. Scale bar is 3 mm. SEM images of an uninfected NIH/
3T3 cell (C) and of a CL-1 cell (D). Budding virus particles are clearly
observed at the CL-1 cell surface. The density of budding events is similar to
what is seen in the AFM images. Virions have native-like dimensions with
diameter of ;120 nm. Scale bar in C and D, is 1 and 2 mm, respectively.
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cells was constantly inspected using standard optical micros-
copy. With this setup, cells remained viable and healthy for
durations exceeding 5 h.
Images of a noninfected NIH/3T3 cell show a relatively
smooth membrane surface (Fig. 1 A). Often it is possible to
identify in the AFM images, ﬁbril structures beneath the
cellular membrane, and these are likely to be cellular cyto-
skeletal elements. In contrast to noninfected cells, images of
the surface of MLV infected CL-1 cells reveal a large amount
of virus particles at different stages of budding. This is
indicated by apparent protrusions of different heights from
the cellular membrane (Fig. 1 B). The width of the particles
appears to be larger than their native dimensions (80–150
nm) (38) due to convolution between the AFM tip and the
virus. Therefore, for the purpose of determining virus dimen-
sions, their width is less accurate than their height. As a
control, noninfected NIH/3T3 and CL-1 cells were imaged
by SEM (Fig. 1, C and D). Similarly to our AFM images,
SEM imaging of noninfected cells shows a smooth mem-
brane surface, whereas imaging of CL-1 membrane shows its
surface to be covered with virus particles having a native
width of;120 nm in diameter (i.e., within the range of their
actual dimensions). Usually we ﬁnd that viral density
decreases with increasing cell passage numbers. We there-
fore imaged cells that had been passaged up to a maximum of
10 times.
Typically, an extremely high concentration of particles on
the cell surface was found during the initial two scans. There-
after, the concentration of particles dropped, and budding
sites were more easily detected.
Real-time imaging of MLV budding
To image budding events with the potential to follow several
budding cycles, cells were imaged repetitively for durations
ranging 1–3 h. Scan areas were set at 10 3 10 mm to
maximize the number of captured budding events. Fre-
quently, scanning areas were decreased to zoom in on
speciﬁc virus particles. Depending on the scan size, imaging
of a single frame took 2–7 min. The resolution of the AFM is
particularly high (subnanometer) in the z-direction (height),
which makes it a powerful tool for monitoring viral budding.
The progress of viral budding was determined by mea-
suring the viral protrusion height as a function of time. Viral
heights were determined manually from their cross sectional
proﬁles (Fig. 2). In this method, single particles were tracked
frame by frame to extract their budding kinetics pattern.
Overall, 64 trajectories of budding events were analyzed in
this study (Fig. 3 A). The majority of events (47 events, 74%)
incorporated a phase during which viral growth was arrested.
This phase began when the virus reached a height near or
equal to its maximal height (Fig. 3, B–D). These budding
trajectories were slow and lasted for over 45 min. Out of
these slow events, we were able to monitor only two com-
plete trajectories, which were composed of three distinct
phases: viral growth, an arrested phase, and a viral release
phase (Fig. 3 B). In all other cases, only minimal lifetime
values could be estimated because partial trajectories were
captured that covered only the ﬁrst two (growth and stalled;
Fig. 3 C) or last two (stalled and release) phases (Fig. 3D), or
just the arrested phase alone (not shown).
The remaining 17 events (26%) exhibited no arrested
phase, which gave rise to faster budding kinetics (Fig. 3 A,
gray column, and E–G). All of the fast kinetics trajectories
covered both the growth phase and the release of the newly
formed virus and were completed in less than 25 min. Inter-
estingly, all fast events had similar growth kinetics of ;10
min. By contrast, the release phase varies between 10 and 15
min and appears to be cell speciﬁc. The averaged trajectories
of budding from three cells are shown in Fig. 3, E–G.
When viewing earlier segments of the budding trajectory,
speciﬁcally, the frames immediately before a particle was
detected, we occasionally observed an elevated region with
an area larger than that of a virus (1–2 mm in diameter). In
addition, often after release of virions, features with heights
slightly larger (;15–20 nm) than the topography of the cell
membrane surroundings remained visible at the site from
which the newly released virion had budded (Fig. 3, E–G,
arrows). These features were no longer detectable during the
following scan, which occurred after roughly 5 min. Further
imaging of this area did not show a regrowth of its height.
Out of all visualized budding sites, successive release of
virus particles from the same location was observed at only
two sites. At one site, four budding events were detected,
FIGURE 2 Visualizing a complete budding progress,
from initial assembly to release of a single virus particle.
AFM height topographic time series images of a virus
particle emerging from live cells (upper panel), with their
corresponding cross sectional proﬁles (lower panel). At t¼
0 min, the emerging bud is seen as a minor protrusion,
located in the center of a larger area that is slightly elevated
from the surrounding cell membrane. After ;20 min, the
bud virion has grown to its maximal height and is released
after an additional 28 min (t ¼ 48 min). Image scan area is
3.1 3 3.1 mm, 80 3 80 pixels. Scale bar is 0.5 mm.
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whereas only two successive events were detected from the
second site (Fig. 4) during the duration of the measurement.
Intriguingly, all the consecutive budding event trajectories
were nearly identical and fast (;12 min for each event).
Moreover, the events occurred continuously without any
observable lag between single events.
Often, particles appeared to be moving slowly in a speciﬁc
direction on the cell surface (Fig. 5). The directions of
movement of different buds were normally independent of
each other. Budding particles were frequently, but not
always, found in proximity to a cytoskeleton element and in
some cases appeared to travel along cellular stress ﬁbers.
DISCUSSION
In this study, real time budding of MLV particles was mon-
itored and analyzed using AFM. Live cells were continuously
imaged for several hours, during which multiple budding
events from the cells’ apical surface were recorded. The AFM
is capable of tracing budding of a single virus due to its high
topographical resolution. To the best of our knowledge, this is
the ﬁrst detailed analysis of single retrovirus particle budding
events. In contrast to bulk measurements of viral budding,
single particle analysis can identify patterns in budding, as
well as different pathways characterized by distinct kinetics.
Indeed, we have found that MLV budding occurs through
at least two pathways, one characterized by fast kinetics, and
the other by slow kinetics. Whereas the fast pathway was
characterized by growth of the newly formed particle to its
maximal height followed by rapid release, the slow pathway
included a stationary or arrested phase between the growth
and release phases, in which the height of the particle re-
mained unchanged. Intuitively, one would speculate that par-
ticles in this arrested phase represent virions which have
completed their budding process but are trapped on the
plasma membrane. If this were the case, these trapped virus
particles would likely be released from the plasma membrane
during image acquisition by the sheer force of the scanning
AFM probe, similarly to the manner in which the initial high
density of virus particles typically observed on the cell’s
plasma membrane during the ﬁrst scan was mostly gone by
the following image. Yet this did not occur, with the newly
formed virion bud remaining visible over subsequent scans.
We therefore conclude that the arrested phase is an integral
part of the slow budding pathway.
The mechanism underlying the observed slow and fast
budding pathways cannot be conclusively determined at this
FIGURE 3 Analysis of the kinetics of single MLV budding events. (A)
All analyzed budding events (64 in total) can be divided into two main
groups according to their kinetics proﬁles: 17 (26%) of the budding events
take place without an arrested phase, giving rise to fast budding kinetics
lasting less than 25 min (gray). The remaining 47 (74%) events are
characterized by a slow budding kinetics, having a lifetime longer than 45
min (black). Out of these slow budding events, two events (4%) were
captured that contain a complete kinetics trajectory, including the growth,
arrested, and release phases (B). The remaining slow budding trajectories
were partially captured, with images obtained of either their ﬁrst two (growth
and arrested; C) or last two (arrested and release,D) phases. (E–G) Averaged
trajectories of fast budding events measured from three different cells (n¼ 4,
3, and 4, respectively). In contrast to the growth rate, which is very similar
for all three cells, slight differences are observed in the release rate (see
portion of curve indicated by an arrow). Features of 15–20 nm in height are
detected ;5 min before the budding site attains its initial height.
FIGURE 4 Consecutive budding events from the same site. Graph shows
height changes as a function of time measured at two locations. At one site,
four rapid repetitive events are detected (solid line), whereas two events are
detected at the second site (dashed line). Within the limitation of our
experimental temporal resolution, no lag time between events is detected.
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stage. However, it may be related to several possible pro-
cesses. In general, viral budding can be divided into two
main steps: the assembly of viral proteins at the cell mem-
brane, which causes it to bend, and the pinching off of the
nascent virus from the membrane. In all of our measure-
ments, the arrested phase appeared after the virion had at-
tained its full, or nearly full, size. Furthermore, the growth
rate of virion particles was found to be very similar for all
analyzed particles, regardless of their overall kinetics. It is
therefore reasonable to assume that the arrested state is
associated with the ﬁssion step rather than with the assembly
step. Recent experimental evidence suggests that efﬁcient
ﬁssion requires recruitment of cellular factors involved in the
endosomal pathways (14). Poor incorporation of these cel-
lular machinery factors may give rise to the observed stalled
phase of the slow budding events. An additional protein that
could impact budding kinetics is viral protease (PR). PR has
been suggested to play a role in the budding process, though
the mechanism is mostly unknown (15,16,39). Alternatively,
the observed two budding kinetics may represent different
Gag protein assembly pathways. Although we cannot com-
pletely rule out this possibility, we consider it unlikely, since
different packaging of Gag will result in different virus
growth rates. Future studies of genetically modiﬁed virus
particles may provide more insights into the mechanisms
which give rise to the kinetically different budding pathways
as, for example, inactivated PR or late-domain mutations are
known to affect virus release.
Comparison between fast budding events originating from
different cells reveals differences primarily in their release
rate, rather than in their growth rate (Fig. 3, E–G). Inter-
estingly, we ﬁnd that the fast budding trajectories of particles
released from the same cell are nearly identical. Several
biophysical models suggest that the ﬁssion step represents an
energetic barrier (40). These models are supported by
experimental evidence which suggests that ATP is required
for ﬁssion (41). It is therefore possible that differences in the
biochemical activities between cells give rise to the observed
variations in viral release.
One of the open questions in retroviral budding is
associated with budding sites. Speciﬁcally, are there unique
sites on the plasma membrane for viral budding? Probably
the strongest evidence supporting an afﬁrmative answer to
this question comes from studies in which mutations were
introduced to the late domain of Gag (10,13). In these
studies, chains of virions have been observed extending from
the plasma membrane, suggesting that virus budding occurs
from a distinct site on cell surfaces. Several other studies
suggest that lipid rafts act as platforms for virus assembly
and budding (reviewed in Briggs et al. (42)). Our results
suggest that viral budding does not occur from unique sites.
Repetitive formation of virus particles from the same site was
observed in only two sites (;3%). This ﬁnding does not
contradict the hypothesis according to which viral budding
occurs from lipid rafts, since rafts are thought to exist as a
rather dynamic and ﬂuid state (43). However, our ﬁndings
contradict the conclusion, drawn from late-domain HIV-1
mutants, that there exist unique sites for viral budding on the
cell membrane. This discrepancy can be explained by dif-
ferences in the budding of wild-type versus late-domain
mutant viruses.
Preassembly and postbudding structural features
A striking and frequent observation was of structural features
that appeared during the preassembly stage and/or after the
nascent virus had been released. We consider the preassembly
FIGURE 5 The movement of a virus on the cell surface. AFM height
topographic time series images of a virus particle (A–D). Images were
acquired at intervals of 6 min. Aligning images using as a reference point the
cell border (black dashed line) and overlaying them on top of each other (E),
reveals a clear directional movement. Scale bar is 2 mm.
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state as being the time point preceding the ﬁrst image in
which a membrane protrusion is identiﬁed. The observed
structural feature in this early state is characterized by a
slightly elevated region whose area (diameter of 1–2 mm) is
signiﬁcantly larger than that of a virus. This structural feature
may represent an initial assembly of Gag proteins underneath
the plasma membrane. Alternatively, this feature may be an
indication of a rearrangement of the cell cytoskeleton.
A similar elevated structural feature was also observed
after the virus had been released from the cell membrane.
However, in contrast to the larger preassembly feature, this
structure has an area similar to that of a virus particle.
Typically, 10–20 min after the release of the virion, this
slightly elevated structure (15–20 nm) disappears. In this
case, we speculate that the observed structure is unlikely to
represent Gag subunits. If it were composed of Gag proteins,
we would expect that a consecutive budding event would
take place from this site instead of it being dissolved. Our
results suggest that this is not the case, since repetitive bud-
ding events from a single site were observed in only two
locations (3%). We therefore conclude that the observed
structure may contain cytoskeletal elements, or alternatively
it may represent budding machinery, such as the ESCRT
(endosomal sorting complex required for transport) complexes
(14), which has yet to disassemble.
In conclusion, we have shown that single virus budding
events can be visualized using AFM. By using a single-
particle analysis approach, distinct patterns normally trans-
parent in bulk measurements were observed. We discovered
that viral budding follows two kinetically distinct pathways.
The results of this study have implications for our under-
standing of the mechanisms underlying virus assembly and
budding. Future studies combining a single-particle ap-
proach with mutated virions hold great potential to provide
new insights into the mechanism that governs viral assembly
and budding.
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